Medicine Press release

Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
More info..

Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
More info..

Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
More info..

Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single largest infectious cause of death in children worldwide.
More info..

Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single largest infectious cause of death in children worldwide.
More info..

Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single largest infectious cause of death in children worldwide.
More info..

NEC Corporation (NEC; TSE: 6701), in collaboration with Chugai Pharmaceutical Co., Ltd., has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments.
More info..

NEC Corporation (NEC; TSE: 6701), in collaboration with Chugai Pharmaceutical Co., Ltd., has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments.
More info..

NEC Corporation (NEC; TSE: 6701), in collaboration with Chugai Pharmaceutical Co., Ltd., has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments.
More info..

Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing, and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2025 ("FY2025" or the "Reporting Period").
More info..